Device type · KPO
Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
KPO
Gastroenterology & Urology
Device class
Class II
FDA decisions since 2015
25
510(k), De Novo and PMA
Adverse event reports
127
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Product code
- KPO
- Device class
- Class II
- Review panel
- Gastroenterology & Urology
- Regulation
- 21 CFR 876.5820
- Specialty
- GI, Urology & Nephrology, Nephrology
- FDA record
- Classification database entry for KPO
Latest FDA decisions
The 8 newest of 25 since 2015.
Nipro Technical Solutions, Incoporated
K260799 · Decided Aug 19, 2026 · 161 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
Fresenius Medical Care Renal Therapies Group, LLC
K253462 · Decided Jan 29, 2026 · 114 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
Fresenius Medical Care Renal Therapies Group, LLC
K252180 · Decided Sep 9, 2025 · 60 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
Fresenius Medical Care Renal Therapies Group, LLC
K243786 · Decided Apr 4, 2025 · 116 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
K240920 · Decided Jul 12, 2024 · 99 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
Fresenius Medical Care Renal Therapies Group, LLC
K233950 · Decided May 10, 2024 · 148 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
K233213 · Decided Jan 18, 2024 · 112 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
Fresenius Medical Care Renal Therapies Group, LLC
K233159 · Decided Dec 1, 2023 · 65 days after receipt
Device type: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO) · GI, Urology & Nephrology
Reports received
127
Received Nov 1, 2025 to Nov 19, 2026. Includes 2 of another or unstated type.
Malfunction reports
123
97% of reports
Injury reports
2
1.6% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 11 | 0 | 0 | 0 |
| Jan 24 | 4 | 0 | 0 | 0 |
| Feb 24 | 4 | 0 | 0 | 0 |
| Mar 24 | 9 | 0 | 0 | 0 |
| Apr 24 | 95 | 1 | 0 | 0 |
| May 24 | 79 | 2 | 0 | 1 |
| Jun 24 | 10 | 1 | 0 | 0 |
| Jul 24 | 15 | 0 | 0 | 0 |
| Aug 24 | 4 | 0 | 0 | 15 |
| Sep 24 | 5 | 0 | 0 | 0 |
| Oct 24 | 7 | 0 | 0 | 0 |
| Nov 24 | 3 | 0 | 0 | 0 |
| Dec 24 | 3 | 1 | 0 | 0 |
| Jan 25 | 11 | 1 | 0 | 0 |
| Feb 25 | 8 | 0 | 0 | 0 |
| Mar 25 | 10 | 1 | 0 | 0 |
| Apr 25 | 6 | 0 | 0 | 0 |
| May 25 | 9 | 2 | 1 | 0 |
| Jun 25 | 27 | 1 | 0 | 0 |
| Jul 25 | 4 | 0 | 1 | 0 |
| Aug 25 | 1 | 1 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 4 | 1 | 0 | 0 |
| Nov 25 | 4 | 0 | 0 | 0 |
| Dec 25 | 2 | 1 | 0 | 1 |
| Jan 26 | 3 | 0 | 0 | 0 |
| Feb 26 | 11 | 0 | 0 | 0 |
| Mar 26 | 83 | 1 | 0 | 0 |
| Apr 26 | 4 | 0 | 0 | 0 |
| May 26 | 2 | 0 | 0 | 0 |
| Jun 26 | 6 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 1 |
| Sep 26 | 5 | 0 | 0 | 0 |
| Oct 26 | 3 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Fluid/Blood Leak78
- Material Separation48
- Defective Component29
- Detachment of Device or Device Component29
- Thermal Decomposition of Device13
- Break8
- Leak/Splash8
- Manufacturing, Packaging or Shipping Problem3
- Fire2
- Smoking2
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions124
- Insufficient Information2
- Hypervolemia1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201Open, Classified
Nipro Renal Soultions USA, Corporation
Z-3133-2026 · Started Aug 5, 2026 · Posted by FDA Sep 10, 2026
Reason given: Hemodialysis concentrates contain high endotoxin levels
Cause as FDA categorized it: Process control
- MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))Open, Classified
Nipro Renal Soultions USA, Corporation
Z-3134-2026 · Started Aug 5, 2026 · Posted by FDA Sep 10, 2026
Reason given: Hemodialysis concentrates contain high endotoxin levels
Cause as FDA categorized it: Process control
Nipro Renal Soultions USA, Corporation
Z-3135-2026 · Started Aug 5, 2026 · Posted by FDA Sep 10, 2026
Reason given: Hemodialysis concentrates contain high endotoxin levels
Cause as FDA categorized it: Process control
Nipro Renal Soultions USA, Corporation
Z-3136-2026 · Started Aug 5, 2026 · Posted by FDA Sep 10, 2026
Reason given: Hemodialysis concentrates contain high endotoxin levels
Cause as FDA categorized it: Process control
- GRANUFLO Dry Acid Concentrate: Product Numbers: 0FD2251-3B; 0FD3251-3B; Dry Acid Concentrate for Bicarbonate HemodialysisOpen, Classified
Fresenius Medical Care Renal Therapies Group, LLC
Z-3091-2026 · Started Jul 14, 2026 · Posted by FDA Sep 3, 2026
Reason given: Complaints of blue-green discoloration in product
Cause as FDA categorized it: Material/Component Contamination
Fresenius Medical Care Renal Therapies Group, LLC
Z-3092-2026 · Started Jul 14, 2026 · Posted by FDA Sep 3, 2026
Reason given: Complaints of blue-green discoloration in product
Cause as FDA categorized it: Material/Component Contamination
Fresenius Medical Care Renal Therapies Group, LLC
Z-3093-2026 · Started Jul 14, 2026 · Posted by FDA Sep 3, 2026
Reason given: Complaints of blue-green discoloration in product
Cause as FDA categorized it: Material/Component Contamination
- Bicarby" Dialysate; Model Numbers: RFP-400-G, RFP-401-G, RFP-402-G, RFP-404-G, RFP-407-G, and RFP-456-G;Open, Classified
Fresenius Medical Care Holdings, Inc.
Z-2321-2026 · Started May 12, 2026 · Posted by FDA Jun 5, 2026
Reason given: Given the increased number of leaks reported by users, it was determined to be the appropriate course of action to notify users of the potential for the occurrence of Bicarby luer-lock leaks during manipulation of the frangible and tubing when preparing the product for use for treatment. This issue presents the...
Cause as FDA categorized it: Process design
Showing the 8 newest of 113 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.